
CPHI & PMEC China 2026
06/2026 – 06/2026
Founded in 1986, the company specializes in manufacturing APIs and pharmaceutical intermediates, with nucleoside antiviral APIs and intermediates and statin antihypertensive APIs and intermediates representing its highest production capacity, widest product range and top-tier quality. Located beside Lake Tai, the company occupies 65,000 square meters with fixed assets of 50 million RMB and more than 360 employees, 20% of whom are technicians.

Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen